Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-03 Option Award |
2025-02-04 4:57 pm |
N/A 2035-02-03 |
Centessa Pharmaceuticals plc | CNTA | Kanes Stephen Chief Medical Officer |
500,000 | $0 | 500,000 (Direct) |
View |
2021-10-19 Option Award |
2021-10-21 4:02 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Kanes Stephen Chief Medical Officer |
3,800 | $0 | 13,471 (Direct) |
View |
2021-10-19 Tax Withholding |
2021-10-21 4:02 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Kanes Stephen Chief Medical Officer |
1,120 | $40.29 | 13,471 (Direct) |
View |
2021-06-15 Option Award |
2021-06-17 09:12 am |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Kanes Stephen Chief Medical Officer |
3,500 | $0 | 10,791 (Direct) |
View |
2021-06-15 Tax Withholding |
2021-06-17 09:12 am |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Kanes Stephen Chief Medical Officer |
1,001 | $58.8 | 10,791 (Direct) |
View |
2021-02-10 Option Award |
2021-02-12 4:01 pm |
N/A 2031-02-10 |
Sage Therapeutics Inc. | SAGE | Kanes Stephen Chief Medical Officer |
19,000 | $0 | 19,000 (Direct) |
View |
2020-04-28 Option Award |
2020-04-30 4:44 pm |
N/A 2030-04-28 |
Sage Therapeutics Inc. | SAGE | Kanes Stephen Chief Medical Officer |
9,450 | $0 | 9,450 (Direct) |
View |